title: Incidence of and risk factors for involvement of the central nervous system in acute myeloid leukemia.
abstract: It is thought that the low incidence of central nervous system (CNS) involvement in acute myeloid leukemia (AML) does not justify routine CNS prophylaxis, as high-dose cytarabine eliminates CNS disease. To investigate whether chemotherapy that does not include high-dose cytarabine increases the risk of CNS involvement, the medical records of 1412 newly diagnosed patients with AML were reviewed. In 1370 patients, lumbar puncture (LP) was performed only if clinically indicated, and CNS disease was detected in 45 (3.3%) patients. Another 42 patients underwent routine LP as part of an investigational protocol, and in eight (19%) CNS disease was detected (p < 0.0001). Risk factors included high lactate dehydrogenase, African-American ethnicity and young age. Patients receiving high-dose cytarabine and those who did not had similar rates of CNS involvement. Disease-free survival (DFS) and overall survival were shorter in patients with CNS involvement. It remains to be determined whether routine CNS prophylaxis would improve DFS.
authors.affiliation: Department of Leukemia, The University of Texas M. D. Anderson Cancer Center , Houston, TX , USA.
authors.forename: Uri
authors.initials: U
authors.lastname: Rozovski
authors.forename: Maro
authors.initials: M
authors.lastname: Ohanian
authors.forename: Farhad
authors.initials: F
authors.lastname: Ravandi
authors.forename: Guillermo
authors.initials: G
authors.lastname: Garcia-Manero
authors.forename: Stefan
authors.initials: S
authors.lastname: Faderl
authors.forename: Sherry
authors.initials: S
authors.lastname: Pierce
authors.forename: Jorge
authors.initials: J
authors.lastname: Cortes
authors.forename: Zeev
authors.initials: Z
authors.lastname: Estrov
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects / Q000627:therapeutic use; D016543:Central Nervous System Neoplasms / Q000175:diagnosis / Q000453:epidemiology* / Q000556:secondary*; D003561:Cytarabine / Q000008:administration & dosage; D005260:Female; D006801:Humans; D015994:Incidence; D015470:Leukemia, Myeloid, Acute / Q000150:complications* / Q000453:epidemiology*; D008297:Male; D008875:Middle Aged; D016017:Odds Ratio; D011379:Prognosis; D012307:Risk Factors; D016019:Survival Analysis; D055815:Young Adult
chemical_list: D003561:Cytarabine
keywords: Acute myeloid leukemia; central nervous system; cytarabine; lumbar puncture; risk factors
references.citation: Lancet. 1986 Nov 29;2(8518):1236-41
references.pmid: 2878130
references.citation: Blood. 1985 Nov;66(5):1062-7
references.pmid: 3840394
references.citation: Int J Radiat Oncol Biol Phys. 2011 May 1;80(1):193-8
references.pmid: 20584584
references.citation: J Clin Oncol. 1983 Sep;1(9):546-51
references.pmid: 6583325
references.citation: Leukemia. 2005 Dec;19(12):2030-42
references.pmid: 16304570
references.citation: Am J Med. 1987 Sep;83(3):464-70
references.pmid: 3661583
references.citation: J Comput Assist Tomogr. 1990 Jul-Aug;14(4):536-41
references.pmid: 2370352
references.citation: Blood. 1985 May;65(5):1071-8
references.pmid: 3857943
references.citation: Cancer. 2012 Jan 1;118(1):112-7
references.pmid: 21692072
references.citation: Pediatr Blood Cancer. 2010 Sep;55(3):414-20
references.pmid: 20658610
references.citation: Leukemia. 2001 Feb;15(2):208-16
references.pmid: 11236936
references.citation: Blood. 2006 Jul 15;108(2):465-72
references.pmid: 16556888
references.citation: Blood. 2004 Jun 1;103(11):4036-42
references.pmid: 14976037
references.citation: Blood. 1995 Sep 15;86(6):2091-7
references.pmid: 7662956
references.citation: Leukemia. 2005 Dec;19(12):2130-8
references.pmid: 16304572
references.citation: Curr Oncol Rep. 2012 Oct;14(5):369-78
references.pmid: 22639108
references.citation: Haematologica. 2010 Nov;95(11):1969-72
references.pmid: 20663946
references.citation: Cancer. 1981 Jan 1;47(1):184-96
references.pmid: 7459807
references.citation: Leukemia. 2003 Nov;17(11):2090-6
references.pmid: 14523477
references.citation: Semin Oncol. 2009 Aug;36(4 Suppl 2):S2-S16
references.pmid: 19660680
references.citation: Leukemia. 2001 Jan;15(1):46-9
references.pmid: 11243398
references.citation: Blood. 2001 Sep 15;98(6):1714-20
references.pmid: 11535502
references.citation: Cancer. 2002 Feb 1;94(3):773-9
references.pmid: 11857312
references.citation: Cancer. 1974 Mar;33(3):863-9
references.pmid: 4521890
references.citation: J Clin Oncol. 2000 Feb;18(3):547-61
references.pmid: 10653870
references.citation: Haematologica. 2011 Sep;96(9):1375-9
references.pmid: 21565904
references.citation: Haematologica. 1997 Sep-Oct;82(5):577-80
references.pmid: 9407724